(Vienna, 12.7.2021) EU funds research project to improve long-term follow-up care for childhood cancer survivors with 4 million euros. In Europe, 35,000 children and adolescents are diagnosed with cancer every year, about 300 of them in Austria. Thanks to better cancer treatments, in recent decades the survival rate has increased…
Survivorship Passport: For a better life after childhood cancer
“1000 Ideas” to boost childhood cancer research: St. Anna CCRI earns two grants in competitive FWF program
(Vienna, 29.06.2021) Two projects from St. Anna Children’s Cancer Research Institute (St. Anna CCRI) receive funding from the “1000 Ideas Programme” of the Austrian Science Fund (FWF). The aim of this program is to support daring and original research ideas that lie outside the current scientific understanding. In the second…
Do you speak immunology? A new language for congenital immune disorders
(Vienna, 30.06.2021) A detailed vocabulary to identify and explore rare, congenital immune disorders around the world? That is exactly what is now available thanks to a new study led by the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases in Vienna and the University Medical Center Groningen. Congenital immune disorders…
Nerve tumor in children: study identifies better tolerable chemotherapy without loss of efficacy
(Vienna, 21.06.2021) The initial chemotherapy of aggressive childhood nerve tumors, so-called high-risk neuroblastomas, is crucial for ultimate survival. It has now been shown that the chemotherapy regimen used by the European Neuroblastoma Study Group is equally efficacious but better tolerated than a highly effective regimen from the US. This was…
Hot off the press: a new role for histone modifications in genomic imprinting
(Vienna, 21.06.2021) Imprinted genes are expressed from either the paternal or maternal allele. Reporting in Nature Communications, scientists led by Martin Leeb have now discovered 71 previously unrecognized imprinted genes in preimplantation blastocysts. The study found that imprinting created by differential histone marks plays a more prominent role in the…
POSTPONED!! “When cells show up on clothes.” Art4Science Panel Discussion on 21.06.2021
POSTPONED!!!! Today, 21.06.2021 at 19:00 St. Anna Children's Cancer Research Institute (CCRI) is organizing the 2nd panel discussion together with the Wiener Zeitung as part of our FWF project Art4Science (www.art4science.at). Art and science are considered two opposing disciplines from which society expects completely different outputs. In the "Art4Science" project,…
Pediatric high-risk tumors: gene defect shortens survival and needs targeted treatment
(Vienna, 11.06.2021) Neuroblastomas, the most common solid tumors outside the brain in children, are associated with poorer survival if they have genetic alterations in the ALK gene and belong to the high-risk group. This was shown by scientists from St. Anna Children's Cancer Research institute together with colleagues in an…
St. Anna CCRI earns WWTF grant to promote precision medicine in childhood cancer
(Vienna, 08.06.2021) St. Anna Children’s Cancer Research Institute is receiving a prestigious Life Science Grant for Precision Medicine, provided by the Vienna Science and Technology Fund (WWTF). Award winner Eleni Tomazou and her colleagues will clinically validate a promising new diagnostic approach, expected to enable precision medicine in childhood tumors…
Blood test detects childhood tumors based on their epigenetic profiles
(Vienna, 28.05.2021) A new study exploits the characteristic epigenetic signatures of childhood tumors to detect, classify and monitor the disease. The scientists analyzed short fragments of tumor DNA that are circulating in the blood. These “liquid biopsy” analyses exploit the unique epigenetic landscape of bone tumors and do not depend…
Clinical Trials Day: a day to say thank you to pediatric cancer researchers!
(Vienna, 20.05.2021) Today's International Clinical Trials Day is a reminder of the scientific progress enabled by clinical trials. Via clinical research, new medicines and other treatments are made available specifically for children with cancer. St. Anna Children's Cancer Research Institute (St. Anna CCRI) has included more than 16,000 patients in…